文献速递临床试验与 GCP

失眠认知行为疗法对比标准认知行为疗法治疗难治性精神分裂症睡眠与昼夜节律紊乱:随机对照试验研究方案

Cognitive behavioral therapy for insomnia vs. standard cognitive behavioral therapy for sleep and circadian disturbances in treatment-resistant schizophrenia: study protocol for the randomized controlled trial (COSTS).
PubMed 文献 · Trials · 2026-04-17

主要假设为CBT-I在改善睡眠障碍方面优于CBT,且睡眠改善与阳性症状改善相关,并预期CBT-I组在睡眠结构客观指标上有改善。

要点

  • CBT-I可能改善难治性精神分裂症患者的睡眠障碍。
  • 睡眠改善可能与阳性症状改善相关。
  • CBT-I或可客观改善睡眠潜伏期、睡眠效率等睡眠结构指标。

核心结论

  • 假设CBT-I在改善难治性精神分裂症患者睡眠障碍方面优于标准CBT,且睡眠改善与阳性症状改善相关。

研究设计与样本

  • 干预为8-10次个体心理治疗,基线、12周和24周随访评估。

关键数值与推荐

  • 主要评估工具包括阳性与阴性症状量表(PANSS)、失眠严重指数(ISI)及多导睡眠图。
  • 12周随访包含多导睡眠图,24周随访不包含多导睡眠图。

临床怎么用

  • 若CBT-I被证实有效,可为难治性精神分裂症患者提供一种成本效益好、短期且可实施的非药物治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A subset of patients with schizophrenia do not respond sufficiently to conventional antipsychotic treatment and often have a more complex clinical course, including high rates of sleep disturbances, which can contribute to further worsening of symptoms. However, sleep disturbances are often overlooked in clinical psychiatric settings, and non-pharmacological treatment options are not initiated. Cognitive behavioral therapy for insomnia (CBT-I) has been shown to effectively ameliorate sleep disturbances in schizophrenia but is yet to be assessed in treatment-resistant schizophrenia. In the present study, we aim to investigate the efficacy of CBT-I versus standard cognitive behavioral therapy (CBT), an active control intervention. METHODS: Sixty patients diagnosed with treatment-resistant schizophrenia and comorbid sleep disturbance will be included in this randomized intervention study. Included patients will be randomized to 8-10 sessions of psychotherapy with either CBT-I (active intervention) or regular CBT (active control) following baseline. At baseline and 12-week follow-up, patients will be assessed with clinical interviews (Positive and Negative Syndrome Scale), self-reported measures (e.g., Insomnia Severity Index), and polysomnography. The 24-week follow-up will include the same assessments apart from polysomnography. The active intervention group will receive an individual course of treatment with CBT-I focused on the patients' sleep patterns, while the active control group will receive an individual course of treatment with standard cognitive behavioral therapy (CBT) focused on patients' psychopathology. It is hypothesized that while both groups will show improvements on central outcome measures, CBT-I will show greater improvements in sleep disturbances. Further, it is hypothesized that the improvement in sleep disturbances will correlate with an improvement in positive symptoms. Lastly, it is anticipated that the CBT-I group will show objective improvements in sleep architecture, such as sleep latency, wake after sleep onset, sleep efficiency, and total sleep time, compared to the CBT group. DISCUSSION: Should CBT-I prove efficacious in improving sleep disturbances in treatment-resistant schizophrenia, it would provide an avenue for a cost-beneficial, short-term, and implementable non-pharmacological treatment of a severe comorbidity in complex schizophrenia patients. Potential issues pertaining to the completion of the study are discussed. TRIAL REGISTRATION: ClinicalTrials.gov NCT06749444. Registered on December 27, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Johansen JF, Nielsen MØ, Kragh M, et al. Cognitive behavioral therapy for insomnia vs. standard cognitive behavioral therapy for sleep and circadian disturbances in treatment-resistant schizophrenia: study protocol for the randomized controlled trial (COSTS). Trials. 2026. PMID: 41998739. doi:10.1186/s13063-026-09482-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。